Venture Valuation is a Swiss headquartered company with a new office in Cavan, Ireland that specializes in the independent assessment and valuation of emerging Life Sciences companies (Biotechnology, Pharmaceutical, and Medical Technologies). In addition to company and product valuations, Venture Valuation offers focused information services, including the global Biotechgate database (www.biotechgate.com).
Venture Valuation has conducted over 400 valuations in Europe, North America and Asia. Clients include investors such as Novartis Venture Fund, GSK, Fraunhofer Gesellschaft, the European Investment Bank and many high growth companies. Venture Valuation also has offices in Canada/US, India and Singapore.